CompletedNCT02411461
Early-onset Obesity and Cognitive Impairment in Children With Pseudohypoparathyroidism
Studying Albright hereditary osteodystrophy
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Vanderbilt University Medical Center
- Principal Investigator
- Ashley Shoemaker, MDVanderbilt University
- Enrollment
- 39 enrolled
- Eligibility
- 6-18 years · All sexes
- Timeline
- 2014 – 2017
Study locations (1)
- Vanderbilt University, Nashville, Tennessee, United States
Collaborators
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02411461 on ClinicalTrials.govOther trials for Albright hereditary osteodystrophy
Additional recruiting or active studies for the same condition.
- ACTIVE NOT RECRUITINGPHASE2NCT04551170Theophylline Treatment for Pseudohypoparathyroidism - Children 2-12 Years OldVanderbilt University Medical Center
- ACTIVE NOT RECRUITINGPHASE2NCT03029429Theophylline Treatment for PseudohypoparathyroidismVanderbilt University Medical Center
- RECRUITINGNANCT00209235Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral AssessmentsConnecticut Children's Medical Center